Narcis Saubi

Publicaciones destacadas

• Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice

  Autores:

  Kilpelainen, Athina; Saubi, Narcis; Guitart, Noria; Moyo, Nathifa; Wee, Edmund G.;

  Ravi, Krupa; Hanke, Tomas; Josep, Joan.

  Referencia: FRONT IMMUNOL.

• MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice

  Autores:

  Broset E; Saubi N; Guitart N; Aguilo N; Uranga S;

  (...)

  Eto Y; Hanke T; Gonzalo-Asensio J; Martín C; Joseph-Munné J.

  Ver listado completo de autores

  Referencia: MOL THER METHODS CLIN DEV.

• Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: Lessons learned

  Autores:

  Kilpeläinen A; Maya-Hoyos M; Saubí N; Soto CY; Joseph Munne J;

  Referencia: EXPERT REVIEW OF VACCINES.

• Recombinant BCG: tHIVconsvX Prime-ChAdOx: tHIVconsvX Boost Regimen Was Safe, Stable and Elicited Specific HIV-1 T-cell Immune Responses in BALB/C Mice

  Autores:

  Kilpelainen, Athina; Saubi, Narcis; Guitart, Nuria; Moyo, Nathifa; Hanke, Tomas;

  Joseph, Joan;.

  Referencia: AIDS RESEARCH AND HUMAN RETROVIRUSES.

• Construction and Characterization of Recombinant MTBVAC. HIV, a New Live Attenuated Vaccine Against HIV and Tuberculosis

  Autores:

  Saubi, Narcis; Broset, Esther; Guitart, Nuria; Aguilo, Nacho; Uranga, Santiago;

  (...)

  Eto, Yoshiki; Hanke, Tomas; Gonzalo-Asensio, Jesus; Martin, Carlos; Joseph, Joan;.

  Ver listado completo de autores

  Referencia: AIDS RESEARCH AND HUMAN RETROVIRUSES.

• Preclinical development of BCG.HIVA^2auxo.int, harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity

  Autores:

  Mahant A.; Saubi N.; Eto Y.; Guitart N.; Gatell J.;

  Hanke T.; Joseph J..

  Referencia: HUMAN VACCINES & IMMUNOTHERAPEUTICS.

• Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG

  Autores:

  Saubi, Narcis; Mbewe-Mvula, Alice; Gea-Mallorqui, Ester; Rosario, Maximillian; Gatell, Josep Maria;

  Hanke, Tomas; Joseph, Joan.

  Referencia: PLOS ONE.

• Newborn mice vaccination with BCG.HIVA(2)(2)(2) + MVA.HIVA enhances HIV-1-specific immune responses: influence of age and immunization routes

  Autores:

  Saubi, Narcis; Im, Eung-Jun; Fernandez-Lloris, Raquel; Gil, Olga; Cardona, Pere-Joan;

  Gatell, Josep Maria; Hanke, Tomas; Joseph, Joan.

  Referencia: CLINICAL AND DEVELOPMENTAL IMMUNOLOGY.

• Engineering New E.coli-Mycobacterial Shuttle Vector for a Dual HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG

  Autores:

  Saubi, N; Gea-Mallorqui, E; Hurtado, C; Hanke, T; Ferrer, P;

  Gatell, J; Joseph, J.

  Referencia: AIDS RESEARCH AND HUMAN RETROVIRUSES 2013.

• Pre-clinical development of BCG.HIVA(CAT) strain, an antibiotic-free selection strain for HIV-TB pediatric vaccine

  Autores:

  Saubi, N; Gea-Mallorqui, E; Mbewe-Mvula, A; Hurtado, C; Gatell, J;

  Hanke, T; Joseph, J.

  Referencia: RETROVIROLOGY 2012.